Synthesis of (11)C-labeled retinoic acid, [(11)C]ATRA, via an alkenylboron precursor by Pd(0)-mediated rapid C-[(11)C]methylation

Bioorg Med Chem Lett. 2014 Aug 1;24(15):3622-5. doi: 10.1016/j.bmcl.2014.05.041. Epub 2014 Jun 2.

Abstract

Retinoids are a class of chemical compounds which include both natural dietary vitamin A (retinol) metabolites and active synthetic analogs. Both experimental and clinical studies have revealed that retinoids regulate a wide variety of essential biological processes. In this study, we synthesized (11)C-labeled all-trans-retinoic acid (ATRA), the most potent biologically active metabolite of retinol and used in the treatment of acute promyelocytic leukemia. The synthesis of (11)C-labeled ATRA was accomplished by a combination of rapid Pd(0)-mediated C-[(11)C]methylation of the corresponding pinacol borate precursor prepared by 8 steps and hydrolysis. [(11)C]ATRA will prove useful as a PET imaging agent, particularly for elucidating the improved therapeutic activity of ATRA (natural retinoid) for acute promyelocytic leukemia by comparing with the corresponding PET probe [(11)C]Tamibarotene (artificial retinoid).

Keywords: (11)C labeling; PET; Retinoids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkenes / chemistry
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / therapeutic use
  • Boron Compounds / chemistry*
  • Carbon Isotopes
  • Catalysis
  • Contrast Media
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Methylation
  • Palladium / chemistry*
  • Positron-Emission Tomography
  • Tretinoin / chemical synthesis*
  • Tretinoin / therapeutic use

Substances

  • Alkenes
  • Antineoplastic Agents
  • Boron Compounds
  • Carbon Isotopes
  • Contrast Media
  • Tretinoin
  • Palladium